Example: quiz answers
HIGHLIGHTS OF PRESCRIBING INFORMATION REPATHA …
Page 3 of 23 o For a once-monthly dose, instruct the patient to administer the dose and start a new schedule based on this date. 2.3 Important Administration Instructions
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Patient Information Single-Dose Prefilled Syringe
www.pi.amgen.comPatient Information Neulasta®(nu-las-tah) (pegfilgrastim) injection Single-Dose Prefilled Syringe What is Neulasta? Neulasta is a man-made form of granulocyte colony-stimulating factor (G-CSF).
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
www.pi.amgen.comPage 3 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Multiple Myeloma and Bone Metastasis from Solid Tumors Xgeva is indicated for the prevention of skeletal-related events in patients with multiple myeloma and in
See full prescribing information for complete boxed warning.
www.pi.amgen.com5 • See Table 2 for the recommended dose by patient weight and schedule. Patients greater than or equal to 45 kg receive a fixed-dose and for patients less than 45 …
HIGHLIGHTS OF PRESCRIBING INFORMATION NEULASTA …
www.pi.amgen.com3 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Patients with CancerReceiving Myelosuppressive Chemotherapy Neulasta is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
www.pi.amgen.comlevels of cinacalcet. Dose adjustment and monitoring of iPTH serum phosphorus and serum calcium may be required. (7.1) Cinacalcet is a strong inhibitor of CYP2D6. Dose adjustments may be required for concomitant medications that are predominantly metabolized by CYP2D6. (7.2)
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
www.pi.amgen.comTransplantation 14.4 Patients Undergoing Autologous Peripheral Blood Progenitor Cell Collection and Therapy 14.5 Patients with Severe Chronic Neutropenia 14.6 Patients Acutely Exposed to Myelosuppressive Doses of Radiation (Hematopoietic Syndrome of Acute Radiation Syndrome) 16 HOW SUPPLIED/STORAGE AND HANDLING
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
www.pi.amgen.com• as a single agent for the treatment of patients with relapsed or refractory multiple myeloma who have received one or more lines of therapy. (1, 14) -----DOSAGE AND ADMINISTRATION----- • Hydrate prior to and following Kyprolis as needed. (2.1)
HIGHLIGHTS OF PRESCRIBING INFORMATION PROLIA.
www.pi.amgen.comLatex Allergy: People sensitive to latex should not handle the gray needle cap on the single-dose prefilled syringe, which contains dry natural rubber (a derivative of latex). Prior to administration, Prolia may be removed from the refrigerator and brought to room temperature (up to 25°C/77°F) by standing in the original container.
Patient Information REPATHA (ri-PAth-a) (evolocumab ...
www.pi.amgen.com1 Patient Information REPATHA® (ri-PAth-a) (evolocumab) injection, for subcutaneous use What is REPATHA? REPATHA is an injectable prescription medicine used:
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
www.pi.amgen.com• To decrease these risks, as well as the risk of serious cardiovascular and thromboembolic reactions, use the lowest dose needed to avoid RBC transfusions [see Dosage and Administration (2.3)]. • Use ESAs only for anemia from myelosuppressive chemotherapy [see Indications and …
Related documents
INTERNATIONAL GCSE - Edexcel
qualifications.pearson.comEnglish as a Second Language within our overall Engli sh offer. More information about all of our qualifications can be found on our Pearson Edexcel International GCSEpages at: qualifications.pearson.com . Pearson Edexcel International GCSE in English Language (Specification A)